Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.

Cancer letters - 8 Feb 2007

Costa Sandra, Pinto Daniela, Pereira Deolinda, Vasconcelos André, Afonso-Lopes Carlos, Osório Teresa, Lopes Carlos, Medeiros Rui

Abstract excerpt

The purpose of this study was to evaluate the role of XPD genotypes as genetic indicator of susceptibility to ovarian cancer. We have used a case-control study. We analysed DNA samples from 141 ovarian cancer patients and 202 control subjects, for three XPD polymorphisms using PCR-RFLP. We observed that Asn312Asn XPD genotype carriers have increased susceptibility of ovarian cancer (OR=2.46 95% CI 1.20-5.06;...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to Gene Frequency

Share to Linkage Disequilibrium

Share to Ovarian Neoplasms

Share to Polymorphism, Restriction Fragment Length

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 16677755
DOI: 10.1016/j.canlet.2006.03.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer.PMID 16677755Read ↗

Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.Semantic proximity Read ↗

Contribution of xeroderma pigmentosum complementation group D gene polymorphisms in breast and ovarian cancer susceptibility: A protocol for systematic review and meta analysis.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.Semantic proximity Read ↗

Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.Semantic proximity Read ↗

Contribution of DNA Repair Xeroderma Pigmentosum Group D Genotypes to Colorectal Cancer Risk in Taiwan.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Association between XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma risk: a systematic review and meta-analysis.Semantic proximity Read ↗

XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis.Semantic proximity Read ↗

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.